{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:04:10Z","timestamp":1785301450787,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"am","delay-in-days":235,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006946","name":"Menninger Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K25DA055156"],"award-info":[{"award-number":["K25DA055156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jad.2025.119727","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:54:58Z","timestamp":1750276498000},"page":"119727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodes"],"prefix":"10.1016","volume":"389","author":[{"given":"Julia","family":"Myerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina A.","family":"Rufino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuntaek","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119727_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jad.2025.119727_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jad.2025.119727_bb0015","first-page":"961","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression. Reply","volume":"389","author":"Anand","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jad.2025.119727_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211006508","article-title":"Excess deaths in treatment-resistant depression","volume":"11","author":"Brenner","year":"2021","journal-title":"Ther Adv Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119727_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ijnp\/pyab088","article-title":"Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT)","volume":"25","author":"Ekstrand","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119727_bb0030","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions","volume":"18","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.119727_bb0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy","volume":"386","author":"Espinoza","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.119727_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1997.tb09926.x","article-title":"Electroconvulsive therapy vs. paroxetine in treatment-resistant depression -- a randomized study","volume":"96","author":"Folkerts","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.119727_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes","year":"2020","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2025.119727_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5498\/wjp.v9.i1.1","article-title":"Electroconvulsive therapy: 80 years old and still going strong","volume":"9","author":"Gazdag","year":"2019","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.jad.2025.119727_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: a statistical approach to defining meaningful change in psychotherapy research","volume":"59","author":"Jacobson","year":"1991","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2025.119727_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17786","article-title":"Ketamine vs electroconvulsive therapy for treatment-resistant depression: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jha","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2025.119727_bb0065","first-page":"489","article-title":"Eighty years of electroconvulsive therapy in Croatia and in Sestre Milosrdnice University Hospital Centre","volume":"59","author":"Karlovic","year":"2020","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.jad.2025.119727_bb0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.119727_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/abr.abr_166_18","article-title":"Comparative effect of intravenous ketamine and electroconvulsive therapy in major depression: a randomized controlled trial","volume":"8","author":"Kheirabadi","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.jad.2025.119727_bb0080","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2025.119727_bb0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/09540260902747888","article-title":"Hollywood and ECT","volume":"21","author":"McDonald","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2025.119727_bb0090","article-title":"Treatment resistant depression: what are the options?","volume":"363","author":"McLachlan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2025.119727_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119727_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.30773\/pi.2020.0350","article-title":"Recent updates on electro-convulsive therapy in patients with depression","volume":"18","author":"Park","year":"2021","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2025.119727_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115994","article-title":"Ketamine versus electroconvulsive therapy for major depressive episode: an updated systematic review and non-inferiority meta-analysis","volume":"339","author":"Petrucci","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.119727_bb0110","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamapsychiatry.2022.3352","article-title":"Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis","volume":"79","author":"Rhee","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.119727_bb0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.119727_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13651501.2017.1297834","article-title":"Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression","volume":"21","author":"Rybakowski","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2025.119727_bb0125","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2022 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2023"},{"key":"10.1016\/j.jad.2025.119727_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Health"},{"key":"10.1016\/j.jad.2025.119727_bb0135","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119727_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200401000-00001","article-title":"A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression","volume":"19","author":"Zimmerman","year":"2004","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725011693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725011693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:56:28Z","timestamp":1776920188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725011693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0165032725011693"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119727","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodes","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119727"}}